Zacks Says Buy KRO, but Wait for Confirmation

What happened

On September 22, 2026, Zacks published a bullish article on Kronos Worldwide (KRO), claiming that TiO2 volumes, market share gains, and pricing improvements are lifting margins and cash flow, supporting a positive 2026 outlook. This stands in contrast to the latest DeepValue master report, which as of February 2026 rated KRO a Wait, citing utilization at only 80% in Q3 2025, ~$27M quarterly unabsorbed fixed costs, rising debt to $626.2M, and weak interest coverage of 1.09x. The master report's thesis explicitly required confirmation of two conditions: sequential realized TiO2 price increases and utilization recovering to at least 85% by Q2 2026, which were not yet evident in the February data. The Zacks article, however, is a single unverified source, likely promotional, and does not provide specific financial metrics or filing references to substantiate its claims of recovery. Insider buying in August 2025 and a subsequent price recovery from $4.40 in November 2025 to $5.91 in February 2026 provided some early positive signals, but formal confirmation is still pending.

Implication

If the claims in the Zacks article are accurate, KRO may be transitioning to the bull scenario with implied value around $8.50, but the article lacks the granular data needed to validate that shift. The master report's bear case, with prices staying flat and utilization stuck at 80-82%, remains plausible if the announced increases did not fully realize. A prudent approach is to monitor the next quarterly filing for proof of sequential realized TiO2 price increases and utilization above 85%, as those were the explicit thesis breakers/confirmers. Until such confirmation, investors should avoid chasing the stock on promotional headlines, especially given the still-high leverage and weak interest coverage. If confirmation arrives, a position could be re-evaluated, but size should reflect the remaining balance sheet risk and cyclicality.

Thesis delta

The original thesis was a Wait, contingent on confirmation of realized TiO2 price increases and utilization recovery. The new Zacks article suggests those conditions may now be met, potentially shifting the thesis toward more constructive if verified. However, because the source is promotional and lacks detailed evidence, no formal shift is warranted until filings confirm the operating improvements.